We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

479 hedge funds and large institutions have $16.1B invested in Allergan plc in 2013 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 166 increasing their positions, 194 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% more call options, than puts

Call options by funds: $342M | Put options by funds: $171M

9% more capital invested

Capital invested by funds: $14.7B → $16.1B (+$1.39B)

6% less funds holding in top 10

Funds holding in top 10: 3230 (-2)

6% less funds holding

Funds holding: 512479 (-33)

14% less repeat investments, than reductions

Existing positions increased: 166 | Existing positions reduced: 194

31% less first-time investments, than exits

New positions opened: 65 | Existing positions closed: 94

Holders
479
Holders Change
-33
Holders Change %
-6.45%
% of All Funds
15.53%
Holding in Top 10
30
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-6.25%
% of All Funds
0.97%
New
65
Increased
166
Reduced
194
Closed
94
Calls
$342M
Puts
$171M
Net Calls
+$170M
Net Calls Change
+$45M
Name Holding Trade Value Shares
Change
Change in
Stake
VanEck Associates
501
VanEck Associates
New York
-$6.52M -51,645 Closed
CI
502
Cowen Inc
New York
-$6.36M -50,400 Closed
Alyeska Investment Group
503
Alyeska Investment Group
Illinois
-$5.93M -47,000 Closed
SAM
504
Symphony Asset Management
California
-$5.47M -43,313 Closed
WIC
505
Water Island Capital
New York
-$5.06M -40,110 Closed
HIMCH
506
Hartford Investment Management Co (HIMCO)
Connecticut
-$4.93M -39,032 Closed
Capstone Investment Advisors
507
Capstone Investment Advisors
New York
-$5.13M -38,501 Closed
EAM
508
EULAV Asset Management
Florida
-$4.67M -37,000 Closed
SGCIA
509
Smith Graham & Co Investment Advisors
Texas
-$4.45M -35,270 Closed
SM
510
Stratton Management
Pennsylvania
-$4.32M -34,240 Closed
AI
511
Analytic Investors
California
-$4.08M -32,283 Closed
RP
512
Raiff Partners
New York
-$4.04M -32,000 Closed
GP
513
GLG Partners
United Kingdom
-$3.66M -29,021 Closed
UOC
514
UBS O'Connor
Illinois
-$3.66M -29,000 Closed
SSWM
515
Sheets Smith Wealth Management
North Carolina
-$3.65M -28,900 Closed
Royal London Asset Management
516
Royal London Asset Management
United Kingdom
-$3.56M -28,270 Closed
Connor, Clark & Lunn Investment Management (CC&L)
517
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$3.74M -28,100 Closed
GACM
518
Green Arrow Capital Management
New York
-$3.53M -28,000 Closed
CIBC World Market
519
CIBC World Market
Ontario, Canada
-$3.53M -27,970 Closed
JGC
520
J. Goldman & Co
New York
-$3.3M -26,116 Closed
PI
521
Placemark Investments
Illinois
-$2.67M -21,184 Closed
NMERB
522
New Mexico Educational Retirement Board
New Mexico
-$2.56M -20,322 Closed
MCM
523
Moore Capital Management
New York
-$2.52M -20,000 Closed
GF
524
Gerry Farber
New York
-$2.08M -16,500 Closed
LSV Asset Management
525
LSV Asset Management
Illinois
-$2.01M -15,900 Closed

AGN Hedge Fund Activity: Q3 2013 in Review

479 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2013, worth a combined $16.1B — up 9.4% from $14.7B a quarter earlier.

Sellers outnumbered buyers: 94 funds closed out of AGN and 65 opened new positions — a net loss of 29 holders — while 194 trimmed existing stakes and 166 added.

The largest buyer was Viking Global Investors, adding an estimated $244M. The largest seller was OppenheimerFunds, cutting an estimated $440M.

  • 479 institutional investors held Allergan plc (AGN) as of Q3 2013, down from 512 in Q2 2013.
  • Funds reported $16.1B of Allergan plc stock for Q3 2013, up 9.4% quarter-over-quarter.
  • 65 funds opened new Allergan plc positions in Q3 2013 and 94 closed out, a net change of -29 holders.
  • The largest Allergan plc buyer in Q3 2013 was Viking Global Investors, an estimated $244M added.
  • The largest Allergan plc seller in Q3 2013 was OppenheimerFunds, an estimated $440M sold.

Based on aggregated 13F filings for Q3 2013.